WuYVYNCJgbkvPvdl
I'm at Liverpool University Zyprexa 5 Immunocore's technology relies on a new type of medicines it calls "ImmTACs." These drugs exploit the power of T cell receptors — a part of the immune system - to recognize changes that occur inside cells during cancer or viral infection. ImmTACs then activate the immune system to kill targeted cells.